Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Sell
2,230,179
-21,103
-0.9% -$32.1K ﹤0.01% 2514
2026
Q1
$4.07M Buy
2,251,282
+1,572,735
+232% +$2.72M ﹤0.01% 2156
2025
Q4
$916K Buy
678,547
+605,459
+828% +$862K ﹤0.01% 2979
2025
Q3
$119K Buy
+73,088
New +$81K ﹤0.01% 3445
2025
Q1
Sell
-319,795
Closed -$257K 3405
2024
Q4
$257K Sell
319,795
-43,923
-12% -$40.2K ﹤0.01% 2787
2024
Q3
$361K Buy
363,718
+235
+0.1% +$323 ﹤0.01% 2601
2024
Q2
$563K Sell
363,483
-662,525
-65% -$1.03M ﹤0.01% 2311
2024
Q1
$1.68M Buy
1,026,008
+868,704
+552% +$728K ﹤0.01% 1607
2023
Q4
$90.5K Buy
157,304
+22,722
+17% +$9.11K ﹤0.01% 2948
2023
Q3
$53.8K Buy
134,582
+80,139
+147% +$39.6K ﹤0.01% 2806
2023
Q2
$29.6K Buy
+54,443
New +$34.9K ﹤0.01% 2881
2023
Q1
Sell
-415,408
Closed -$540K 3137
2022
Q4
$540K Buy
415,408
+278,131
+203% +$433K ﹤0.01% 1988
2022
Q3
$244K Buy
+137,277
New +$342K ﹤0.01% 2033
2020
Q3
Sell
-62,404
Closed -$14K 3421
2020
Q2
$14K Buy
+62,404
New +$18.8K ﹤0.01% 2872
2020
Q1
Sell
-98,400
Closed -$51K 3632
2019
Q4
$51K Buy
+98,400
New +$97.8K ﹤0.01% 3570
2019
Q1
Sell
-298
Closed -$2K 3353
2018
Q4
$2K Buy
+298
New +$9.49K ﹤0.01% 2906

Other funds holding OCGN

John Overdeck's OCGN Position: Q2 2026 in Review

John Overdeck reduced its Ocugen (OCGN) stake by 0.94% in Q2 2026, selling an estimated $32.1K and leaving 2,230,179 shares worth $3.41M. The position accounts for ﹤0.01% of the portfolio, ranked #2514.

John Overdeck first reported a position in OCGN in Q4 2018 and has held it in 16 quarters since. The position peaked at $4.07M in Q1 2026. 146 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • John Overdeck held 2,230,179 shares of Ocugen worth $3.41M as of Q2 2026.
  • John Overdeck sold 21,103 Ocugen shares in Q2 2026, an estimated $32.1K.
  • Ocugen made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2514 holding.
  • John Overdeck first reported a position in Ocugen in Q4 2018 and has held it in 16 quarters since.
  • John Overdeck's Ocugen position peaked at $4.07M in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.